Brief: Chromadex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement And $5 Million Investment

Niagen Bioscience

11/10/2022 12:46

Oct 11 (Reuters) - Chromadex Corp  CDXC.O :
    * CHROMADEX AND NESTLÉ HEALTH SCIENCE ANNOUNCE NEW NIAGEN®
COMMERCIAL SUPPLY AGREEMENT AND $5 MILLION INVESTMENT
    * CHROMADEX CORP - AGREEMENT INCLUDES AN INITIAL NIAGEN
INGREDIENT
PURCHASE COMMITMENT OF $1.975 MILLION IN 2022
    * CHROMADEX CORP - NEW AGREEMENT EXTENDS NON-EXCLUSIVE
RIGHTS TO
SELL NIAGEN(®) IN MULTI-INGREDIENT DIETARY SUPPLEMENTS
    * CHROMADEX CORP - CO TO BE ELIGIBLE TO RECEIVE COMMERCIAL
MILESTONE PAYMENTS, AS WELL AS TIERED ROYALTIES, RELATED TO SALE
OF NESTLÉ'S NIAGEN PRODUCTS

Source text for Eikon:  ID:nBw8xlTjqa 
Further company coverage:  CDXC.O 
 ((Reuters.Briefs@thomsonreuters.com;))